Theoretical versus empirical allometry: Facts behind theories and application to pharmacokinetics.
about
Efficacy of a metalloproteinase inhibitor in spinal cord injured dogs.Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.Scaling adult doses of antifungal and antibacterial agents to childrenOptimal dosing of miltefosine in children and adults with visceral leishmaniasis.Dried blood spots and sparse sampling: a practical approach to estimating pharmacokinetic parameters of caffeine in preterm infants.Prediction of Human Glomerular Filtration Rate from Preterm Neonates to Adults: Evaluation of Predictive Performance of Several Empirical ModelsOptimizing drug development of anti-cancer drugs in children using modelling and simulation.Advances in paediatric pharmacokinetics.Evaluation of a morphine maturation model for the prediction of morphine clearance in children: how accurate is the predictive performance of the model?Prediction of clearance and volume of distribution in the obese from normal weight subjects: an allometric approach.Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults.Prediction of morphine clearance in the paediatric population : how accurate are the available pharmacokinetic models?Methods for pharmacokinetic analysis in young children.Prediction of glucuronidated drug clearance in pediatrics (≤5 years): An allometric approach.Prediction of drug clearance in children: an evaluation of the predictive performance of several models.Prediction of drug clearance in children: a review of different methodologies.Prediction of Drug Clearance in Premature and Mature Neonates, Infants, and Children ≤2 Years of Age: A Comparison of the Predictive Performance of 4 Allometric Models.Population Pharmacokinetics: Some Observations in Pediatric Modeling for Drug Clearance.Prediction of Clearance and Volume of Distribution in the Obese from Normal Weight Subjects : An Allometric Approach.Population pharmacokinetic modelling of recombinant factor IX Fc fusion protein (rFIXFc) in patients with haemophilia B.Prediction of Clearance, Volume of distribution, and Half-life of Drugs in Extremely Low to Low Birth Weight Neonates: An Allometric Approach.Prediction of infant drug exposure through breastfeeding: population PK modeling and simulation of fluoxetine exposure.Self-organization of developing embryo using scale-invariant approach.Allometric Scaling of Clearance in Paediatric Patients: When Does the Magic of 0.75 Fade?Allometric or lean body mass scaling of propofol pharmacokinetics: towards simplifying parameter sets for target-controlled infusions.Of mice, men and nanoparticle biocoronas: are in vitro to in vivo correlations and interspecies extrapolations realistic?A bodyweight-dependent allometric exponent model for scaling clearance of clotting factor VIII and IX from infants to adults.Response to the comments of Professors Anderson & Holford.The influence of body size descriptors on the estimation of kidney function in normal weight, overweight, obese, and morbidly obese adults.
P2860
Q33553427-1BB2CEF6-82C4-42BC-9745-11789538C3F0Q34299078-A259D2FB-4E97-4678-B9CA-244668B03187Q36018577-80301BD8-651F-4BF1-9BBE-131BF7611F64Q36086339-5EB3A365-B08F-469C-A20D-C1E21127E511Q36620231-1DE70682-4549-485B-A42C-14F74616F758Q36653892-B17B3ED0-529D-4646-9EAD-56C578554D9CQ36987975-10650EA3-CD93-451D-AEBF-10E313267F3FQ37813680-671A10EE-832D-46F3-8F00-C359B65E76DEQ37818515-98FD4E09-F338-4232-8299-29E7A0F282E6Q38016504-185E2493-E7A8-45CA-9D02-F5FDBEB64B52Q38019839-10122D92-2516-4713-9931-35316C46B9B9Q38047202-53A1149B-9843-4C53-8469-6EDC76645EDEQ38187157-42EF15AD-59A6-4489-AF3B-FFDE99C43021Q38187348-5D74E7D0-9903-416C-A8E2-C1977AB507C3Q38256006-34B87F1E-D4AF-4CA4-AE13-8A88AF07988AQ38367747-2428901E-4882-412F-A4B4-61B126D02534Q38599526-B02F60DA-6EA5-455A-BA13-74073BF92CAAQ38838930-45031B33-0713-4439-A2A8-273A6E20E64FQ38930369-C6833C72-EF8A-4550-9B6B-3A12544F275CQ38935228-E2BBDF31-F0ED-4B43-84D4-EB87B800B93FQ38937378-058815B4-236E-4A02-A8F7-D5E00728A3D1Q39756442-01661D33-3460-45CD-BBA4-98B641853CA1Q41786066-87D1301F-75B3-4E04-B19C-401D77B4A184Q42320775-BED22BEB-4553-4E6A-8962-D711126CE5FCQ42635454-255FA708-8583-4D2F-8A2F-09E099E8BED3Q44403669-499E6638-2D3D-481D-A9B2-CFE90821A107Q45862027-00C6BD4E-2373-4A8F-B95A-F241B34175F7Q46477241-5A81F718-AB47-4DEF-B394-689BD26C9D9BQ47323100-6351E5A6-1F80-4FA8-A7E4-D746310D078C
P2860
Theoretical versus empirical allometry: Facts behind theories and application to pharmacokinetics.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Theoretical versus empirical a ...... plication to pharmacokinetics.
@en
Theoretical versus empirical a ...... plication to pharmacokinetics.
@nl
type
label
Theoretical versus empirical a ...... plication to pharmacokinetics.
@en
Theoretical versus empirical a ...... plication to pharmacokinetics.
@nl
prefLabel
Theoretical versus empirical a ...... plication to pharmacokinetics.
@en
Theoretical versus empirical a ...... plication to pharmacokinetics.
@nl
P356
P1476
Theoretical versus empirical a ...... plication to pharmacokinetics.
@en
P2093
Iftekhar Mahmood
P304
P356
10.1002/JPS.22073
P407
P577
2010-07-01T00:00:00Z